The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

被引：0
|
作者：
Gennaro Galasso
Gaetano Santulli
Federico Piscione
Roberta De Rosa
Valentina Trimarco
Raffaele Piccolo
Salvatore Cassese
Guido Iaccarino
Bruno Trimarco
Massimo Chiariello
机构：
[1] Federico II University School of Medicine,Department of Clinical Medicine, Cardiovascular and Immunologic Sciences
来源：
BMC Cardiovascular Disorders | / 10卷
关键词：
Percutaneous Coronary Intervention; Acute Myocardial Infarction; Transient Ischemic Attack; Peripheral Artery Disease; Major Adverse Cardiac Event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Heartbeat: hospitalisation for COVID-19 is associated with an increased risk of subsequent adverse cardiovascular events
    Otto, Catherine M.
    HEART, 2023, 109 (02) : 79 - 81
  • [32] Low testosterone is associated with increased risk of major adverse cardiovascular events in smokers with erectile dysfunction
    Ioakeimidis, N.
    Georgakopoulos, C.
    Terentes-Printzios, D.
    Dima, I.
    Gardikioti, V.
    Angelis, A.
    Gourgouli, I.
    Tsioufis, K.
    Vlachopoulos, C.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2601 - 2601
  • [33] PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement
    Kastrati, A
    Koch, W
    Gawaz, M
    Mehilli, J
    Böttiger, C
    Schömig, K
    von Beckerath, N
    Schömig, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 84 - 89
  • [34] Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass
    Mathew, JP
    Rinder, CS
    Howe, JG
    Fontes, M
    Crouch, J
    Newman, MF
    Phillips-Bute, B
    Smith, BR
    ANNALS OF THORACIC SURGERY, 2001, 71 (02): : 663 - 666
  • [35] Diclofenac associated with increased risk of major cardiovascular events
    Swannell, Cate
    MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (07) : 284 - 284
  • [36] Testosterone therapy associated with increased risk of cardiovascular events
    Nature Reviews Cardiology, 2014, 11 (1) : 2 - 2
  • [37] Cardiovascular adverse events not increased with salmeterol
    Reactions Weekly, 1999, 748 (1) : 4 - 4
  • [38] Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study
    Zhao, Boya
    Wu, Jing
    Lu, Chengzhi
    Feng, Xing Lin
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [39] Family history of syncope is associated with increased risk of adverse cardiovascular events and mortality - a Danish nationwide study
    Zahir, D.
    Ruwald, M. H.
    Bruun, L. E.
    Nume, A. K.
    Torp-Pedersen, C.
    Gislason, G. H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 548 - 548
  • [40] Platelet glycoprotein receptor IIIa polymorphism PlA1/PlA2 and coronary risk:: a meta-analysis
    Di Castelnuovo, A
    de Gaetano, G
    Donati, MB
    Iacoviello, L
    THROMBOSIS AND HAEMOSTASIS, 2001, 85 (04) : 626 - 633
12345